¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ ![WX -"lW  
sDnHd9v<?t  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© #5GIO  
JGPLVw  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© BM*9d%m^  
[B9'/:  
1.Co-stimulators (or co-stimulating molecules) G l+[ |?N  
I]P'wav~O  
2.NK-kB orn9;|8q  
$x5P 5^Y  
3.Immunoglobulin superfamily D3V5GQ\=  
3jPua)=p  
4.antigen-presenting cell (APC) Uw^`_\si  
Z]l<,m  
5.death domain y0qrl4S)v  
hK9Trrwau  
6.CCR and CXCR kH1hsDe|&y  
Pk[:+. f(  
7.Lectin (or mitogen) U>6MT@\  
Z8nj9X$   
8.Clusters of differentiation, CD) \|nF55W [  
d_=@1 JM>  
9.B7 family V0 x[sEW  
%se4aeOrX  
10.Cytotoxic T lymphocyte, CTL) 9tsI1]1[m  
/%|JP{   
11.IL-15 and IL-15 receptor (IL-15R) 'Ca6cm3Tg  
m8eyAvi 6  
12.MHC restriction ^pZ1uN!b  
Twyx(~'&R  
13.Affinity-chromatography c^vP d]Ed  
;LE4U OK  
14.Cyctosprin A, CsA $E3- </ f  
:b)IDcW&j:  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ~K}iVX  
$X8(OS5d'  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© zY~  
^;jJVYx-PP  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 yQE|FbiA  
lo*OmAF  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ 0"7%*n."2  
v+uq  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ f =@'F=  
m3W:\LTTp  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© {Q],rv|;  
3qJOE6[}%  
ÃâÒßѧרҵ£º li'h&!|]  
4?Pdld  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ r09gB#K4  
'i5 VU4?K  
Ïû»¯ÄÚ¿Æ£º 8* 7t1$  
0_'(w;!wq:  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ZoX24C '  
e ewhT ^  
ѪҺ²¡Ñ§×¨Òµ£º e R Y2.!  
<xpOi&l  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
5+2=? ÕýÈ·´ð°¸:7
°´"Ctrl+Enter"Ö±½ÓÌá½»